JP2006524702A5 - - Google Patents

Download PDF

Info

Publication number
JP2006524702A5
JP2006524702A5 JP2006513275A JP2006513275A JP2006524702A5 JP 2006524702 A5 JP2006524702 A5 JP 2006524702A5 JP 2006513275 A JP2006513275 A JP 2006513275A JP 2006513275 A JP2006513275 A JP 2006513275A JP 2006524702 A5 JP2006524702 A5 JP 2006524702A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
hydrogen
defined above
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006513275A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006524702A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/012645 external-priority patent/WO2004096822A2/en
Publication of JP2006524702A publication Critical patent/JP2006524702A/ja
Publication of JP2006524702A5 publication Critical patent/JP2006524702A5/ja
Pending legal-status Critical Current

Links

JP2006513275A 2003-04-25 2004-04-23 ピリジル置換ケトライド抗体 Pending JP2006524702A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46529403P 2003-04-25 2003-04-25
PCT/US2004/012645 WO2004096822A2 (en) 2003-04-25 2004-04-23 Pyridyl substituted ketolide antibiotics

Publications (2)

Publication Number Publication Date
JP2006524702A JP2006524702A (ja) 2006-11-02
JP2006524702A5 true JP2006524702A5 (https=) 2007-05-24

Family

ID=33418219

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006513275A Pending JP2006524702A (ja) 2003-04-25 2004-04-23 ピリジル置換ケトライド抗体

Country Status (5)

Country Link
US (1) US7332476B2 (https=)
EP (1) EP1618119A2 (https=)
JP (1) JP2006524702A (https=)
CA (1) CA2523134A1 (https=)
WO (1) WO2004096822A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
EP3290427A1 (en) 2005-08-24 2018-03-07 Melinta Therapeutics, Inc. Triazole compounds and methods of making and using the same
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ,インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) * 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
WO2012089349A2 (en) 2010-12-31 2012-07-05 Acies Bio D.O.O. Novel polyketide compounds and methods of making same
JP5718488B2 (ja) * 2011-03-01 2015-05-13 ウォックハート リミテッド ケトライド中間体の調製方法
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
WO2018044808A1 (en) * 2016-08-29 2018-03-08 Board Of Regents, University Of Texas System Inhibitors of dual leucine ziper (dlk) kinase for the treatment of disease
WO2018067663A2 (en) * 2016-10-04 2018-04-12 Biopharmati Sa Ketolides having antibacterial activity
KR20190087622A (ko) 2016-12-08 2019-07-24 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 질환 치료를 위한 이중 류신 지퍼 (dlk) 키나아제의 바이시클로[1.1.1]펜탄 억제제
US11560366B2 (en) 2019-10-21 2023-01-24 Board Of Regents, The University Of Texas System Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857641A (en) 1987-08-14 1989-08-15 Pfizer Inc. C.12 modified erythromycin A derivatives
US6063561A (en) * 1991-01-17 2000-05-16 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
JP2000509712A (ja) * 1996-05-07 2000-08-02 アボツト・ラボラトリーズ 6―o―置換エリスロマイシン及びその製造方法
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US6191118B1 (en) 1996-11-27 2001-02-20 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
US6140479A (en) 1997-03-24 2000-10-31 Taisho Pharmaceuticals Co., Ltd. Erythromycin a derivatives
CA2451391A1 (en) * 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives

Similar Documents

Publication Publication Date Title
JP2006524702A5 (https=)
CA2632626C (en) Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection
JP2006524706A5 (https=)
JP2020169171A5 (https=)
JP2003514903A5 (https=)
JP2005526857A5 (https=)
JP2007191486A5 (https=)
JP2005526107A5 (https=)
JP2005525991A5 (https=)
JP2004531544A5 (https=)
JP2006505543A5 (https=)
JP2012503621A5 (https=)
JP2008523082A5 (https=)
JP2007502295A5 (https=)
JP2010511018A5 (https=)
JP2007520452A5 (https=)
JP2004506740A5 (https=)
JP2006507355A5 (https=)
RU2008145714A (ru) Пуриновые производные в качестве активатора аденозинового рецептора
JP2007500707A5 (https=)
JP2002543114A5 (https=)
JP2004531478A5 (https=)
JP2019519593A5 (https=)
JP2006503805A5 (https=)
JP2018527360A5 (https=)